Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Health Behavior | 30 | 2023 | 2617 | 4.990 |
Why?
|
Acute Coronary Syndrome | 19 | 2021 | 2180 | 3.710 |
Why?
|
Depression | 37 | 2023 | 8057 | 3.260 |
Why?
|
Heart Diseases | 17 | 2020 | 2782 | 2.700 |
Why?
|
Patient Compliance | 11 | 2020 | 2685 | 2.230 |
Why?
|
Anxiety Disorders | 16 | 2021 | 2714 | 2.180 |
Why?
|
Psychotherapy | 11 | 2020 | 1640 | 2.170 |
Why?
|
Psychiatry | 10 | 2022 | 1689 | 1.950 |
Why?
|
Hematopoietic Stem Cell Transplantation | 13 | 2024 | 5649 | 1.950 |
Why?
|
Health Promotion | 14 | 2023 | 2204 | 1.900 |
Why?
|
Anxiety | 15 | 2023 | 4539 | 1.820 |
Why?
|
Exercise | 20 | 2022 | 5788 | 1.550 |
Why?
|
Quality of Life | 21 | 2024 | 13285 | 1.300 |
Why?
|
Depressive Disorder | 10 | 2018 | 3727 | 1.290 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2023 | 12075 | 1.290 |
Why?
|
Suicidal Ideation | 11 | 2022 | 1430 | 1.260 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15399 | 1.240 |
Why?
|
Inpatients | 12 | 2022 | 2551 | 1.230 |
Why?
|
Depressive Disorder, Major | 14 | 2023 | 4745 | 1.180 |
Why?
|
Hematologic Neoplasms | 6 | 2024 | 1890 | 1.180 |
Why?
|
Behavior Therapy | 5 | 2021 | 869 | 1.170 |
Why?
|
Antidepressive Agents | 12 | 2020 | 2889 | 1.140 |
Why?
|
Chest Pain | 5 | 2022 | 1090 | 1.140 |
Why?
|
Feasibility Studies | 17 | 2023 | 5199 | 1.140 |
Why?
|
Psychosomatic Medicine | 5 | 2015 | 71 | 1.110 |
Why?
|
Mental Disorders | 11 | 2021 | 6803 | 1.100 |
Why?
|
Cooperative Behavior | 7 | 2017 | 1501 | 1.090 |
Why?
|
Bariatric Surgery | 4 | 2021 | 986 | 1.080 |
Why?
|
Panic Disorder | 5 | 2016 | 613 | 1.080 |
Why?
|
Long QT Syndrome | 3 | 2017 | 465 | 1.070 |
Why?
|
Heart Failure | 13 | 2023 | 11593 | 1.070 |
Why?
|
Antipsychotic Agents | 11 | 2022 | 3060 | 1.070 |
Why?
|
Anti-Anxiety Agents | 5 | 2013 | 397 | 1.010 |
Why?
|
Emotions | 6 | 2021 | 2734 | 1.000 |
Why?
|
Torsades de Pointes | 2 | 2017 | 78 | 0.950 |
Why?
|
Psychomotor Agitation | 3 | 2016 | 304 | 0.910 |
Why?
|
Patient Simulation | 2 | 2016 | 297 | 0.910 |
Why?
|
Pilot Projects | 16 | 2024 | 8553 | 0.890 |
Why?
|
Humans | 180 | 2024 | 758406 | 0.870 |
Why?
|
Psychotherapy, Group | 4 | 2019 | 412 | 0.870 |
Why?
|
Stress, Psychological | 8 | 2024 | 4455 | 0.850 |
Why?
|
Renal Insufficiency | 3 | 2023 | 809 | 0.810 |
Why?
|
Personal Satisfaction | 3 | 2019 | 643 | 0.800 |
Why?
|
Coronary Artery Disease | 7 | 2020 | 6362 | 0.800 |
Why?
|
Affect | 2 | 2019 | 1480 | 0.750 |
Why?
|
Happiness | 3 | 2019 | 170 | 0.740 |
Why?
|
Patient Care Team | 7 | 2016 | 2504 | 0.720 |
Why?
|
Delirium | 5 | 2022 | 1663 | 0.700 |
Why?
|
Telemedicine | 5 | 2021 | 3018 | 0.700 |
Why?
|
Middle Aged | 70 | 2024 | 219568 | 0.670 |
Why?
|
Attitude to Health | 3 | 2015 | 2026 | 0.660 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2017 | 932 | 0.640 |
Why?
|
Attitude | 2 | 2013 | 777 | 0.600 |
Why?
|
Mental Health Services | 3 | 2020 | 1718 | 0.590 |
Why?
|
Bipolar Disorder | 5 | 2018 | 5079 | 0.580 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2018 | 6013 | 0.570 |
Why?
|
Male | 78 | 2024 | 358747 | 0.560 |
Why?
|
Telephone | 4 | 2022 | 625 | 0.550 |
Why?
|
Arrhythmias, Cardiac | 6 | 2014 | 2248 | 0.550 |
Why?
|
Female | 81 | 2024 | 390323 | 0.540 |
Why?
|
Myocardial Infarction | 7 | 2013 | 11424 | 0.510 |
Why?
|
Self Care | 2 | 2018 | 794 | 0.510 |
Why?
|
Clinical Competence | 4 | 2016 | 4775 | 0.500 |
Why?
|
Aged | 45 | 2024 | 168218 | 0.480 |
Why?
|
Outpatients | 2 | 2022 | 1591 | 0.480 |
Why?
|
Qualitative Research | 7 | 2020 | 2976 | 0.480 |
Why?
|
Cardiovascular Agents | 3 | 2011 | 839 | 0.470 |
Why?
|
Internship and Residency | 5 | 2016 | 5865 | 0.470 |
Why?
|
Motor Activity | 2 | 2015 | 2685 | 0.470 |
Why?
|
Mental Health | 8 | 2022 | 3234 | 0.460 |
Why?
|
Research Subjects | 1 | 2016 | 249 | 0.450 |
Why?
|
Motivation | 3 | 2020 | 1996 | 0.440 |
Why?
|
Neurology | 1 | 2021 | 778 | 0.430 |
Why?
|
Primary Health Care | 7 | 2021 | 4652 | 0.430 |
Why?
|
Chronic Disease | 6 | 2023 | 9267 | 0.420 |
Why?
|
Psychotropic Drugs | 2 | 2017 | 883 | 0.410 |
Why?
|
Program Development | 2 | 2016 | 1298 | 0.410 |
Why?
|
Interleukin-1 | 1 | 2016 | 1249 | 0.400 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2014 | 431 | 0.400 |
Why?
|
Obesity, Morbid | 2 | 2021 | 1277 | 0.400 |
Why?
|
Comorbidity | 7 | 2022 | 10495 | 0.400 |
Why?
|
Leukemia | 1 | 2020 | 1519 | 0.390 |
Why?
|
Weight Loss | 2 | 2020 | 2671 | 0.390 |
Why?
|
Catatonia | 3 | 2017 | 178 | 0.380 |
Why?
|
Suicide | 5 | 2022 | 1599 | 0.380 |
Why?
|
Naturopathy | 1 | 2010 | 13 | 0.370 |
Why?
|
Teaching | 2 | 2016 | 1168 | 0.370 |
Why?
|
Editorial Policies | 1 | 2015 | 456 | 0.370 |
Why?
|
Referral and Consultation | 4 | 2016 | 3586 | 0.370 |
Why?
|
Models, Psychological | 1 | 2015 | 830 | 0.370 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3175 | 0.360 |
Why?
|
Adult | 43 | 2024 | 219935 | 0.360 |
Why?
|
Borderline Personality Disorder | 3 | 2018 | 765 | 0.350 |
Why?
|
Patient Readmission | 2 | 2015 | 3261 | 0.350 |
Why?
|
Health Facilities | 1 | 2015 | 578 | 0.350 |
Why?
|
Suicide, Attempted | 4 | 2022 | 1383 | 0.350 |
Why?
|
Myelodysplastic Syndromes | 1 | 2020 | 1392 | 0.350 |
Why?
|
Coronary Stenosis | 1 | 2016 | 793 | 0.340 |
Why?
|
Single-Blind Method | 4 | 2016 | 1570 | 0.340 |
Why?
|
Personality Inventory | 2 | 2010 | 1018 | 0.340 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3812 | 0.330 |
Why?
|
Ambulatory Care | 1 | 2020 | 2768 | 0.330 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2024 | 4560 | 0.320 |
Why?
|
Hydrocortisone | 1 | 2016 | 1802 | 0.300 |
Why?
|
Citalopram | 2 | 2017 | 402 | 0.290 |
Why?
|
Irritable Bowel Syndrome | 2 | 2023 | 453 | 0.280 |
Why?
|
Hospitalization | 7 | 2022 | 10652 | 0.280 |
Why?
|
Obesity | 2 | 2020 | 12870 | 0.280 |
Why?
|
Self-Assessment | 2 | 2021 | 393 | 0.270 |
Why?
|
Medication Adherence | 3 | 2022 | 2155 | 0.270 |
Why?
|
Electroconvulsive Therapy | 2 | 2008 | 500 | 0.260 |
Why?
|
Interleukin-6 | 1 | 2016 | 3208 | 0.260 |
Why?
|
Survivors | 4 | 2024 | 2370 | 0.260 |
Why?
|
Attitude of Health Personnel | 2 | 2013 | 3867 | 0.250 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1185 | 0.240 |
Why?
|
Empathy | 2 | 2019 | 473 | 0.240 |
Why?
|
Lorazepam | 1 | 2005 | 154 | 0.240 |
Why?
|
Periodicals as Topic | 1 | 2015 | 1462 | 0.230 |
Why?
|
Treatment Outcome | 16 | 2022 | 64378 | 0.230 |
Why?
|
Benzodiazepines | 2 | 2016 | 1130 | 0.230 |
Why?
|
Follow-Up Studies | 11 | 2017 | 39059 | 0.230 |
Why?
|
Mood Disorders | 3 | 2018 | 1124 | 0.230 |
Why?
|
Hyperparathyroidism | 1 | 2005 | 337 | 0.230 |
Why?
|
Rage | 1 | 2003 | 30 | 0.230 |
Why?
|
Munchausen Syndrome | 1 | 2003 | 19 | 0.230 |
Why?
|
Prospective Studies | 14 | 2023 | 54137 | 0.220 |
Why?
|
Educational Measurement | 1 | 2010 | 1248 | 0.220 |
Why?
|
Treatment Refusal | 2 | 2003 | 429 | 0.220 |
Why?
|
Psychopharmacology | 1 | 2005 | 148 | 0.220 |
Why?
|
Self Concept | 2 | 2019 | 1041 | 0.220 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 3992 | 0.220 |
Why?
|
Anti-Infective Agents | 1 | 2011 | 981 | 0.220 |
Why?
|
Antihypertensive Agents | 2 | 2011 | 2016 | 0.220 |
Why?
|
Nurse-Patient Relations | 1 | 2003 | 100 | 0.220 |
Why?
|
Risk Factors | 16 | 2023 | 73809 | 0.210 |
Why?
|
Hypercalcemia | 1 | 2005 | 421 | 0.210 |
Why?
|
Acetaminophen | 2 | 2003 | 552 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.210 |
Why?
|
Health Care Costs | 1 | 2016 | 3245 | 0.210 |
Why?
|
Hepatic Encephalopathy | 1 | 2003 | 144 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.200 |
Why?
|
Diagnosis, Differential | 8 | 2016 | 12951 | 0.200 |
Why?
|
Quinolones | 1 | 2005 | 377 | 0.200 |
Why?
|
Schizophrenia | 3 | 2010 | 6910 | 0.200 |
Why?
|
Drug Therapy, Combination | 2 | 2011 | 6293 | 0.200 |
Why?
|
Restraint, Physical | 1 | 2003 | 186 | 0.200 |
Why?
|
Myocardial Ischemia | 3 | 2017 | 2108 | 0.190 |
Why?
|
Heart Failure, Systolic | 1 | 2023 | 135 | 0.190 |
Why?
|
Waiting Lists | 2 | 2016 | 762 | 0.190 |
Why?
|
Brugada Syndrome | 1 | 2022 | 95 | 0.190 |
Why?
|
Pandemics | 2 | 2021 | 8611 | 0.190 |
Why?
|
Cholesterol | 1 | 2010 | 2902 | 0.190 |
Why?
|
Migraine Disorders | 1 | 2013 | 1694 | 0.180 |
Why?
|
Acute Disease | 4 | 2016 | 7225 | 0.180 |
Why?
|
Interdisciplinary Communication | 2 | 2016 | 931 | 0.180 |
Why?
|
Intensive Care Units | 1 | 2013 | 3732 | 0.170 |
Why?
|
Anticonvulsants | 2 | 2022 | 1881 | 0.170 |
Why?
|
Severity of Illness Index | 6 | 2012 | 15785 | 0.170 |
Why?
|
Interviews as Topic | 2 | 2020 | 2676 | 0.170 |
Why?
|
Guilt | 1 | 2020 | 96 | 0.170 |
Why?
|
Psychometrics | 4 | 2022 | 3052 | 0.170 |
Why?
|
Self Efficacy | 2 | 2022 | 632 | 0.170 |
Why?
|
Regression Analysis | 3 | 2016 | 6354 | 0.160 |
Why?
|
Caregivers | 2 | 2024 | 2225 | 0.160 |
Why?
|
Mass Screening | 3 | 2010 | 5427 | 0.160 |
Why?
|
Neurotransmitter Agents | 1 | 2022 | 663 | 0.160 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2008 | 1214 | 0.160 |
Why?
|
Thiophenes | 1 | 2003 | 569 | 0.150 |
Why?
|
Diabetes Mellitus | 2 | 2013 | 5816 | 0.150 |
Why?
|
Diet | 4 | 2022 | 8005 | 0.150 |
Why?
|
Meditation | 1 | 2021 | 251 | 0.150 |
Why?
|
Adaptation, Psychological | 3 | 2018 | 2629 | 0.150 |
Why?
|
Curriculum | 2 | 2016 | 3717 | 0.150 |
Why?
|
Iran | 1 | 2020 | 737 | 0.140 |
Why?
|
Individuality | 1 | 2019 | 300 | 0.140 |
Why?
|
Aged, 80 and over | 10 | 2023 | 58683 | 0.140 |
Why?
|
Inflammation | 1 | 2017 | 10718 | 0.140 |
Why?
|
Computer Systems | 1 | 2018 | 470 | 0.140 |
Why?
|
Social Support | 3 | 2018 | 2155 | 0.140 |
Why?
|
Actigraphy | 1 | 2021 | 518 | 0.140 |
Why?
|
Relaxation Therapy | 1 | 2018 | 179 | 0.140 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2005 | 2197 | 0.140 |
Why?
|
Coronary Artery Bypass | 2 | 2016 | 2189 | 0.140 |
Why?
|
Therapy, Computer-Assisted | 1 | 2018 | 266 | 0.140 |
Why?
|
Loneliness | 1 | 2018 | 196 | 0.130 |
Why?
|
Spouses | 1 | 2018 | 279 | 0.130 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25956 | 0.130 |
Why?
|
Health Personnel | 1 | 2010 | 3312 | 0.130 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2018 | 261 | 0.130 |
Why?
|
Vitamin D Deficiency | 1 | 2005 | 1377 | 0.130 |
Why?
|
Transplantation, Homologous | 1 | 2024 | 4809 | 0.130 |
Why?
|
Endothelin-1 | 1 | 2017 | 302 | 0.130 |
Why?
|
Health Status | 3 | 2016 | 4071 | 0.130 |
Why?
|
Monitoring, Ambulatory | 1 | 2018 | 352 | 0.130 |
Why?
|
Body Image | 1 | 2020 | 637 | 0.120 |
Why?
|
Piperazines | 1 | 2005 | 2511 | 0.120 |
Why?
|
Feedback | 1 | 2018 | 791 | 0.120 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 130 | 0.120 |
Why?
|
Risk Assessment | 5 | 2022 | 23884 | 0.120 |
Why?
|
Asthma | 1 | 2013 | 6172 | 0.120 |
Why?
|
Young Adult | 8 | 2022 | 58808 | 0.120 |
Why?
|
Altruism | 1 | 2016 | 205 | 0.110 |
Why?
|
Sickness Impact Profile | 1 | 2015 | 298 | 0.110 |
Why?
|
Risk | 2 | 2016 | 9599 | 0.110 |
Why?
|
Habits | 1 | 2014 | 146 | 0.110 |
Why?
|
Physician-Patient Relations | 2 | 2003 | 3242 | 0.110 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1125 | 0.110 |
Why?
|
Patient Discharge | 3 | 2021 | 3433 | 0.110 |
Why?
|
Publications | 1 | 2015 | 194 | 0.100 |
Why?
|
Likelihood Functions | 1 | 2016 | 987 | 0.100 |
Why?
|
Pituitary-Adrenal System | 1 | 2016 | 551 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 892 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7810 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1185 | 0.100 |
Why?
|
Social Work | 1 | 2013 | 159 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2003 | 2325 | 0.100 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2016 | 699 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4919 | 0.100 |
Why?
|
Models, Economic | 1 | 2016 | 715 | 0.100 |
Why?
|
Hypertension | 2 | 2018 | 8499 | 0.100 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2751 | 0.100 |
Why?
|
Academies and Institutes | 1 | 2013 | 319 | 0.100 |
Why?
|
Saliva | 1 | 2016 | 820 | 0.100 |
Why?
|
Fear | 1 | 2020 | 1462 | 0.090 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2011 | 92 | 0.090 |
Why?
|
Social Work, Psychiatric | 1 | 2011 | 23 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1433 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14490 | 0.090 |
Why?
|
Self Report | 3 | 2017 | 3714 | 0.090 |
Why?
|
Time Factors | 5 | 2021 | 39872 | 0.090 |
Why?
|
Electrocardiography | 3 | 2022 | 6363 | 0.090 |
Why?
|
Odds Ratio | 2 | 2013 | 9650 | 0.090 |
Why?
|
Education, Medical, Graduate | 2 | 2015 | 2359 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2017 | 908 | 0.090 |
Why?
|
Research Design | 3 | 2021 | 6157 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 918 | 0.090 |
Why?
|
Psychotic Disorders | 1 | 2005 | 3193 | 0.090 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 344 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2007 | 1240 | 0.090 |
Why?
|
Medical Audit | 1 | 2011 | 452 | 0.090 |
Why?
|
Hospitals, Psychiatric | 1 | 2011 | 320 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2016 | 10146 | 0.080 |
Why?
|
Health Resources | 1 | 2016 | 931 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3024 | 0.080 |
Why?
|
Multifactorial Inheritance | 1 | 2017 | 1365 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 1 | 2016 | 1722 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12096 | 0.080 |
Why?
|
Prognosis | 4 | 2021 | 29557 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1386 | 0.080 |
Why?
|
Personality | 1 | 2012 | 552 | 0.080 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 1704 | 0.080 |
Why?
|
Coronary Care Units | 1 | 2010 | 235 | 0.080 |
Why?
|
Prevalence | 3 | 2022 | 15651 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2012 | 1593 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13591 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15225 | 0.070 |
Why?
|
Fatigue | 2 | 2020 | 1542 | 0.070 |
Why?
|
Coronary Disease | 1 | 2022 | 5917 | 0.070 |
Why?
|
Problem-Based Learning | 1 | 2010 | 352 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3425 | 0.070 |
Why?
|
Heart Block | 1 | 2008 | 392 | 0.070 |
Why?
|
Cognition | 1 | 2004 | 6953 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 1 | 2012 | 787 | 0.070 |
Why?
|
Recurrence | 2 | 2008 | 8426 | 0.070 |
Why?
|
Drug Utilization | 1 | 2011 | 1187 | 0.060 |
Why?
|
Treatment Failure | 1 | 2011 | 2640 | 0.060 |
Why?
|
Community Mental Health Services | 1 | 2008 | 392 | 0.060 |
Why?
|
Mortality | 1 | 2016 | 2886 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5103 | 0.060 |
Why?
|
Algorithms | 2 | 2021 | 13961 | 0.060 |
Why?
|
Atenolol | 1 | 2005 | 99 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5098 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 438 | 0.060 |
Why?
|
Awareness | 1 | 2008 | 644 | 0.060 |
Why?
|
Specialization | 1 | 2009 | 776 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2015 | 4451 | 0.060 |
Why?
|
Reinforcement Schedule | 1 | 2003 | 123 | 0.060 |
Why?
|
Sick Role | 1 | 2003 | 230 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5484 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6493 | 0.050 |
Why?
|
Catecholamines | 1 | 2003 | 385 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10112 | 0.050 |
Why?
|
Acetylcholinesterase | 1 | 2022 | 156 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3322 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4402 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8451 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9273 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2003 | 261 | 0.050 |
Why?
|
Length of Stay | 2 | 2017 | 6439 | 0.050 |
Why?
|
Internal-External Control | 1 | 2003 | 359 | 0.050 |
Why?
|
Benchmarking | 1 | 2008 | 1042 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1988 | 0.050 |
Why?
|
Personality Assessment | 1 | 2003 | 650 | 0.050 |
Why?
|
Cohort Studies | 4 | 2022 | 41256 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7378 | 0.050 |
Why?
|
Haloperidol | 1 | 2022 | 388 | 0.050 |
Why?
|
Inservice Training | 1 | 2003 | 375 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2307 | 0.040 |
Why?
|
Adolescent | 5 | 2022 | 87892 | 0.040 |
Why?
|
Stroke | 1 | 2003 | 9694 | 0.040 |
Why?
|
Aging | 1 | 2019 | 8650 | 0.040 |
Why?
|
Risperidone | 1 | 2022 | 379 | 0.040 |
Why?
|
Students, Medical | 1 | 2013 | 1927 | 0.040 |
Why?
|
Boston | 1 | 2013 | 9304 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2024 | 701 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2003 | 419 | 0.040 |
Why?
|
Progesterone | 1 | 2024 | 742 | 0.040 |
Why?
|
Mentors | 1 | 2005 | 660 | 0.040 |
Why?
|
Social Perception | 1 | 2003 | 432 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2010 | 2215 | 0.040 |
Why?
|
Interprofessional Relations | 1 | 2005 | 989 | 0.040 |
Why?
|
Heart Rate | 2 | 2021 | 4166 | 0.040 |
Why?
|
Logistic Models | 1 | 2013 | 13276 | 0.040 |
Why?
|
Health Services | 1 | 2003 | 752 | 0.040 |
Why?
|
Relaxation | 1 | 2018 | 51 | 0.040 |
Why?
|
Psychiatric Department, Hospital | 1 | 2018 | 126 | 0.040 |
Why?
|
Cardiology | 1 | 2008 | 1667 | 0.040 |
Why?
|
Occupational Health Services | 1 | 2018 | 150 | 0.040 |
Why?
|
United States | 4 | 2022 | 72136 | 0.040 |
Why?
|
Self-Injurious Behavior | 1 | 2003 | 556 | 0.040 |
Why?
|
Patients | 1 | 2023 | 904 | 0.040 |
Why?
|
Massachusetts | 1 | 2010 | 8823 | 0.030 |
Why?
|
Estradiol | 1 | 2024 | 1933 | 0.030 |
Why?
|
Analgesics | 1 | 2003 | 1064 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2003 | 835 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8530 | 0.030 |
Why?
|
Brain | 1 | 2022 | 26947 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17768 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 910 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4580 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 9051 | 0.030 |
Why?
|
Disease Progression | 1 | 2012 | 13468 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1554 | 0.030 |
Why?
|
Group Processes | 1 | 2015 | 226 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2011 | 22029 | 0.030 |
Why?
|
Social Environment | 1 | 2018 | 1023 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22032 | 0.030 |
Why?
|
Gender Identity | 1 | 2018 | 757 | 0.030 |
Why?
|
Social Behavior | 1 | 2018 | 1131 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3227 | 0.020 |
Why?
|
Incidence | 1 | 2010 | 21272 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3701 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14641 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2022 | 2055 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3420 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2005 | 4504 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1740 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3887 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2008 | 314 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1936 | 0.020 |
Why?
|
Lymphocytosis | 1 | 2008 | 119 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 7985 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2008 | 544 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7818 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20500 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2008 | 914 | 0.010 |
Why?
|
Animals | 1 | 2015 | 167768 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9404 | 0.010 |
Why?
|
Drug Resistance | 1 | 2008 | 1593 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2003 | 15637 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16534 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20055 | 0.010 |
Why?
|
Videotape Recording | 1 | 1998 | 337 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 80168 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18358 | 0.010 |
Why?
|
Interview, Psychological | 1 | 1998 | 809 | 0.010 |
Why?
|
Angiography | 1 | 1998 | 1599 | 0.010 |
Why?
|
Electroencephalography | 1 | 2008 | 6187 | 0.010 |
Why?
|